Derrick J. Rossi
Fundador en Stelexis Therapeutics LLC .
Perfil
Derrick J.
Rossi is the founder of ModernaTX, Inc. (founded in 2011), Intellia Therapeutics, Inc. (founded in 2014), Magenta Therapeutics, Inc. (founded in 2015), Moderna, Inc. (founded in 2010), and Stelexis Therapeutics LLC (founded in 2017) where he holds the title of Director.
Currently, Dr. Rossi is the Chief Executive Officer & Director at New York Stem Cell Foundation, Inc. (since 2010), President, Chief Executive Officer & Director at Convelo Therapeutics, Inc., and Director at Ophirex, Inc. Dr. Rossi obtained his undergraduate and graduate degrees from the University of Toronto and a doctorate degree from the University of Helsinki in 2003.
Cargos activos de Derrick J. Rossi
| Empresas | Cargo | Inicio |
|---|---|---|
Stelexis Therapeutics LLC
 Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | Fundador | 01/01/2017 |
Convelo Therapeutics, Inc.
 Convelo Therapeutics, Inc. BiotechnologyHealth Technology Convelo Therapeutics, Inc. develops medicines that unlock the regenerative capacity of the central nervous system. The company was founded by Paul Tesar and Drew Adams in 2016 and is headquartered in Cleveland, OH. | Director Ejecutivo | - |
| New York Stem Cell Foundation, Inc. | Director Ejecutivo | - |
Ophirex, Inc.
 Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Derrick J. Rossi.
| Empresas | Cargo | Fin |
|---|---|---|
| MODERNA, INC. | Fundador | - |
| INTELLIA THERAPEUTICS, INC. | Fundador | - |
| MAGENTA THERAPEUTICS | Fundador | - |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Fundador | - |
Formación de Derrick J. Rossi.
| University of Toronto | Graduate Degree |
| University of Helsinki | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | Health Technology |
Convelo Therapeutics, Inc.
Convelo Therapeutics, Inc. BiotechnologyHealth Technology Convelo Therapeutics, Inc. develops medicines that unlock the regenerative capacity of the central nervous system. The company was founded by Paul Tesar and Drew Adams in 2016 and is headquartered in Cleveland, OH. | Health Technology |
| New York Stem Cell Foundation, Inc. | Miscellaneous |
Ophirex, Inc.
Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Derrick J. Rossi